Literature DB >> 7698521

When do brain abnormalities in cerebral palsy occur? An MRI study.

T Sugimoto1, M Woo, N Nishida, A Araki, T Hara, A Yasuhara, Y Kobayashi, Y Yamanouchi.   

Abstract

The authors used MRI to analyse retrospectively the brain images of patients with cerebral palsy (CP) to evaluate its the role in the assessment of brain abnormalities and injury, and the relationship of pre-, peri- and postnatal events to CP. 70 patients with CP aged two to 16 years who underwent MRI were divided into four groups: group 1 (26 patients) comprised subjects whose CP was considered to have been caused by neuronal migration disorders in the embryonal stage; group 2 (30 patients) contained subjects whose cause was vascular disorders; in group 3 patients (five) the cause was intra-uterine infection; and CP clearly attributable to birth asphyxia (group 4) was noted in only nine patients. The results indicate that CP of term infants is often the result of prenatal factors, and their MRI findings indicated migration and cerebral infarction. Brain MRI is an essential examination in identifying the factors causing brain damage in CP.

Entities:  

Mesh:

Year:  1995        PMID: 7698521     DOI: 10.1111/j.1469-8749.1995.tb12007.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

Review 1.  Cerebral palsy--medicolegal aspects.

Authors:  I Blumenthal
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2. 

Authors:  R H Largo; K von Siebenthal
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

3.  Australian Cerebral Palsy Child Study: protocol of a prospective population based study of motor and brain development of preschool aged children with cerebral palsy.

Authors:  Roslyn N Boyd; Rachel Jordan; Laura Pareezer; Anne Moodie; Christine Finn; Belinda Luther; Evyn Arnfield; Aaron Pym; Alex Craven; Paula Beall; Kelly Weir; Megan Kentish; Meredith Wynter; Robert Ware; Michael Fahey; Barry Rawicki; Lynne McKinlay; Andrea Guzzetta
Journal:  BMC Neurol       Date:  2013-06-11       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.